This is a research study to measure the effect of digoxin injection on Dilation and Evacuation (D\&E) procedure duration. Digoxin is the most commonly used feticidal agent among family planning subspecialists, and is commonly used for a variety of reasons including provider preference, patient preference, and concerns over legal status of later D\&E procedures. There have been several studies on digoxin administration, adverse effects, and impact on the D\&E procedure, but doctors want to clarify how digoxin effects D\&E procedure time, if at all.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Enrollment
178
FPA Women's Health
Long Beach, California, United States
SFGH Women's Options Center
San Francisco, California, United States
Lovejoy Surgicenter
Portland, Oregon, United States
Procedure Duration
First instrument into uterus until procedure complete
Time frame: Beginning to end of procedure (between 5 minutes and 1 hour)
Total Procedure Duration
Time from speculum placed until all instruments removed from vagina (including speculum and fingers) and done with everything
Time frame: done on Day 2 during the procedure
Measured Blood Loss
measured blood loss, in mL, during the procedure, measured by weighing the absorbent materials used and subtracting out their weight without blood
Time frame: Day 2, during the procedure
Number of Patients With Reported Fetal Death Prior to Procedure
number of patients who had fetal death measured by ultrasound
Time frame: Day 2, before procedure
Complications
hemorrhage, perforation, cervical laceration requiring suture repair, out-of-hospital delivery, infection, inability to complete injection, other complications of the injection itself, and patient symptoms such as nausea and vomiting
Time frame: Day 2
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.